查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1586001

COVID-19 檢測市場：按套件類型、測試類型、檢體類型、應用分類 - 2025-2030 年全球預測

COVID-19 Testing Market by Kit Type (Rapid Test Kit, Real-Time Reverse Transcription Polymerase Chain Reaction ), Test Type, Specimen Type, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023 年，COVID-19 測試市場估值為 388.4 億美元，預計到 2024 年將達到 426.2 億美元，複合年成長率為 10.20%，預計到 2030 年將達到 766.9 億美元。

COVID-19 檢測市場的範圍和定義包括用於檢測個人 SARS-CoV-2 病毒的診斷工具的生產和分銷。該市場主要包括PCR檢測、抗原檢測和抗體檢測，旨在快速診斷感染，以進行病毒分離、治療和預防傳播。人們強調，COVID-19 檢測是疫情期間公共衛生管理的重要工具，不僅在醫療保健領域，而且在確保職場和社區安全運作的經濟活動中也產生了影響。測試應用不僅限於臨床環境，還滲透到旅行、娛樂、教育和職場等領域，展示了廣泛的最終用途。

主要市場統計
基準年[2023] 388.4億美元
預測年份 [2024] 426.2億美元
預測年份 [2030] 766.9億美元
複合年成長率（%） 10.20%

市場開拓洞察表明，由於對公共衛生的日益關注以及政府對開發更有效率、更快速的診斷測試的支持等因素，預計將出現強勁成長。尤其是，諸如家用檢測套組、用於高效結果管理的數位健康整合以及使用穿戴式生物感測器的新型測試等創新測試技術的潛在商機已經成熟。然而，挑戰仍然存在，包括測試準確性的變化、供應鏈限制以及市場進入的監管障礙，這可能會影響市場擴張。此外，獲得測試機會的差異仍然是影響整體測試市場滲透率的重大問題。

創新機會在於開發更具成本效益、更快且更易於存取的測試解決方案，重點是易於分散的 POC 系統。人工智慧和機器學習也有成長潛力，可以增強資料解釋，以及用於遠端監控和測試的遠端醫療系統。市場動態具有適應性，本質上是動態和競爭的，受到監管變化、技術進步、新變體和公共衛生政策導致的需求變化的影響。為了實現永續成長，企業必須提高供應鏈彈性，擴大檢測物流的數位基礎設施，並為多樣化的檢測解決方案建立合作夥伴關係，以滿足新出現的公共衛生需求。

市場動態：揭示快速發展的 COVID-19 檢測市場的關鍵市場洞察

COVID-19 檢測市場正在因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球 COVID-19 感染患者數量增加
    • 政府越來越主動實施大規模測試
    • 積極努力生產改良的 COVID-19檢測套組
  • 市場限制因素
    • 擔心診斷試劑套件短缺
  • 市場機會
    • 新參與企業專注於家庭測試並整合先進軟體
    • COVID-19 檢測設備的開發與創新
  • 市場挑戰
    • 測試結果不正確的問題

波特五力：駕馭 COVID-19 檢測市場的策略工具

波特五力框架是了解 COVID-19 測試市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解 COVID-19 檢測市場的外部影響

外部宏觀環境因素在塑造 COVID-19 測試市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解 COVID-19 檢測市場的競爭格局

對 COVID-19 測試市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣 COVID-19 測試市場供應商的績效評估

FPNV 定位矩陣是評估 COVID-19 測試市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了在 COVID-19 測試市場中的成功之路

對於旨在加強其在全球市場的影響力的公司來說，COVID-19 檢測市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球新冠肺炎 (COVID-19) 感染人數不斷增加
      • 政府加大力度進行大規模檢測
      • 大量投資生產改良的 COVID-19檢測套組
    • 抑制因素
      • 擔心診斷試劑套件短缺
    • 機會
      • 新參與企業專注於家庭測試和高級軟體整合
      • COVID-19檢測設備的開發與創新
    • 任務
      • 測試結果不正確的問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第 6 章 按套件類型分類的 COVID-19 測試市場

  • 快速檢測套組
  • 即時逆轉錄聚合酵素鏈鎖反應(RT-PCR)

第 7 章 按測試類型分類的 COVID-19 測試市場

  • 多重NAAT
  • NAAT照護現場
  • 單重核酸增幅檢查

第8章 COVID-19 測試市場樣本類型

  • 血
  • 鼻拭子
  • 鼻咽拭子
  • 口咽拭子
  • 尿

第 9 章 COVID-19 測試市場：按應用分類

  • 診所
  • 診斷中心
  • 醫院

第 10 章 美洲的 COVID-19 檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區 COVID-19 檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的COVID-19檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • AccuBioTech Co. Ltd.
  • ADT Biotech
  • AIVD Biotech Inc.
  • Altona Diagnostics GmbH
  • AMEDA Labordiagnostik GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Cepheid Inc.
  • Coris BioConcept SPRL
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • GenBody America, LLC
  • Genuine Biosystem Pvt. Ltd.
  • Hologic Inc.
  • LAB-CARE DIAGNOSTICS（INDIA）PVT. LTD.
  • Laboratory Corporation of America Holdings
  • Luminex Corporation
  • PerkinElmer Inc.
  • Quest Diagnostics Inc.
  • Quidel Corporation
  • SD Biosensor, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-02026C4C986E

The COVID-19 Testing Market was valued at USD 38.84 billion in 2023, expected to reach USD 42.62 billion in 2024, and is projected to grow at a CAGR of 10.20%, to USD 76.69 billion by 2030.

The scope and definition of the COVID-19 testing market encompass the production and distribution of diagnostic tools used to detect the SARS-CoV-2 virus in individuals. This market primarily includes PCR tests, antigen tests, and antibody tests, structured to promptly diagnose infection for timely isolation, treatment, and prevention of virus transmission. The necessity of COVID-19 testing was highlighted during the pandemic as a crucial tool in managing public health, supporting not just the healthcare sector but also influencing economic activities by ensuring workplaces and communities can function safely. Testing applications extend beyond clinical settings, permeating sectors such as travel, entertainment, education, and workplaces, marking its widespread end-use scope.

KEY MARKET STATISTICS
Base Year [2023] USD 38.84 billion
Estimated Year [2024] USD 42.62 billion
Forecast Year [2030] USD 76.69 billion
CAGR (%) 10.20%

Market insights indicate robust growth driven by factors such as a heightened public health focus and government support for developing more efficient and rapid diagnostic tests. There's a conducive environment for potential opportunities, particularly in innovative testing technologies like at-home testing kits, digital health integration for efficient results management, and novel test types using wearable biosensors. However, challenges endure, including variability in test accuracy, supply chain constraints, and regulatory hurdles in market entry, which may impact market expansion. Furthermore, disparities in testing access remain a critical issue affecting overall testing market penetration.

Innovation opportunities lie in developing more cost-effective, rapid, and accessible testing solutions, with emphasis on easy-to-distribute Point-of-Care systems. There's also potential growth in artificial intelligence and machine learning to enhance data interpretation and in telehealth systems for remote monitoring and testing. The COVID-19 testing market is adaptive, with a dynamic and competitive nature influenced by regulatory changes, technological advancements, and fluctuating demand driven by new variants and public health policies. For sustained growth, businesses should focus on improving supply chain resilience, expanding digital infrastructure for testing logistics, and forging collaborations for diversified testing solutions to cater to emergent public health needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving COVID-19 Testing Market

The COVID-19 Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of COVID-19-infected patients globally
    • Rising government initiatives toward the implementation of mass testing
    • Significant invetsments to manufacture improved COVID-19 testing kits
  • Market Restraints
    • Concerns associated with scarcity of diagnostic kits
  • Market Opportunities
    • Focus of new entrants toward at-home testing and integration of advanced software
    • Development and innovations in COVID-19 testing devices
  • Market Challenges
    • Issues pertaining to false test results

Porter's Five Forces: A Strategic Tool for Navigating the COVID-19 Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the COVID-19 Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the COVID-19 Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the COVID-19 Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the COVID-19 Testing Market

A detailed market share analysis in the COVID-19 Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the COVID-19 Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the COVID-19 Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the COVID-19 Testing Market

A strategic analysis of the COVID-19 Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the COVID-19 Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuBioTech Co. Ltd., ADT Biotech, AIVD Biotech Inc., Altona Diagnostics GmbH, AMEDA Labordiagnostik GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Cepheid Inc., Coris BioConcept SPRL, Danaher Corporation, F. Hoffmann-La Roche AG, GenBody America, LLC, Genuine Biosystem Pvt. Ltd., Hologic Inc., LAB-CARE DIAGNOSTICS (INDIA) PVT. LTD., Laboratory Corporation of America Holdings, Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Inc., Quidel Corporation, SD Biosensor, Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the COVID-19 Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Kit Type, market is studied across Rapid Test Kit and Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR).
  • Based on Test Type, market is studied across Multiplex NAATs, NAAT Point of Care, and Singleplex Nucleic Acid Amplification Tests.
  • Based on Specimen Type, market is studied across Blood, Nasal Swab, Nasopharyngeal Swab, Oropharyngeal Swab, and Urine.
  • Based on Application, market is studied across Clinics, Diagnostic Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of COVID-19-infected patients globally
      • 5.1.1.2. Rising government initiatives toward the implementation of mass testing
      • 5.1.1.3. Significant invetsments to manufacture improved COVID-19 testing kits
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with scarcity of diagnostic kits
    • 5.1.3. Opportunities
      • 5.1.3.1. Focus of new entrants toward at-home testing and integration of advanced software
      • 5.1.3.2. Development and innovations in COVID-19 testing devices
    • 5.1.4. Challenges
      • 5.1.4.1. Issues pertaining to false test results
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. COVID-19 Testing Market, by Kit Type

  • 6.1. Introduction
  • 6.2. Rapid Test Kit
  • 6.3. Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR)

7. COVID-19 Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Multiplex NAATs
  • 7.3. NAAT Point of Care
  • 7.4. Singleplex Nucleic Acid Amplification Tests

8. COVID-19 Testing Market, by Specimen Type

  • 8.1. Introduction
  • 8.2. Blood
  • 8.3. Nasal Swab
  • 8.4. Nasopharyngeal Swab
  • 8.5. Oropharyngeal Swab
  • 8.6. Urine

9. COVID-19 Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Clinics
  • 9.3. Diagnostic Centers
  • 9.4. Hospitals

10. Americas COVID-19 Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific COVID-19 Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa COVID-19 Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AccuBioTech Co. Ltd.
  • 3. ADT Biotech
  • 4. AIVD Biotech Inc.
  • 5. Altona Diagnostics GmbH
  • 6. AMEDA Labordiagnostik GmbH
  • 7. Becton, Dickinson and Company
  • 8. Bio-Rad Laboratories, Inc.
  • 9. bioMerieux SA
  • 10. Cepheid Inc.
  • 11. Coris BioConcept SPRL
  • 12. Danaher Corporation
  • 13. F. Hoffmann-La Roche AG
  • 14. GenBody America, LLC
  • 15. Genuine Biosystem Pvt. Ltd.
  • 16. Hologic Inc.
  • 17. LAB-CARE DIAGNOSTICS (INDIA) PVT. LTD.
  • 18. Laboratory Corporation of America Holdings
  • 19. Luminex Corporation
  • 20. PerkinElmer Inc.
  • 21. Quest Diagnostics Inc.
  • 22. Quidel Corporation
  • 23. SD Biosensor, Inc.
  • 24. Siemens Healthineers AG
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. COVID-19 TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. COVID-19 TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COVID-19 TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES COVID-19 TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES COVID-19 TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. COVID-19 TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. COVID-19 TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COVID-19 TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COVID-19 TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COVID-19 TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COVID-19 TESTING MARKET SIZE, BY RAPID TEST KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COVID-19 TESTING MARKET SIZE, BY REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COVID-19 TESTING MARKET SIZE, BY MULTIPLEX NAATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COVID-19 TESTING MARKET SIZE, BY NAAT POINT OF CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COVID-19 TESTING MARKET SIZE, BY SINGLEPLEX NUCLEIC ACID AMPLIFICATION TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COVID-19 TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COVID-19 TESTING MARKET SIZE, BY NASAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COVID-19 TESTING MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COVID-19 TESTING MARKET SIZE, BY OROPHARYNGEAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COVID-19 TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COVID-19 TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COVID-19 TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL COVID-19 TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES COVID-19 TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. COVID-19 TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. COVID-19 TESTING MARKET, FPNV POSITIONING MATRIX, 2023